1. Home
  2. OPK vs BFS Comparison

OPK vs BFS Comparison

Compare OPK & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • BFS
  • Stock Information
  • Founded
  • OPK 2007
  • BFS 1993
  • Country
  • OPK United States
  • BFS United States
  • Employees
  • OPK N/A
  • BFS N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • BFS Real Estate Investment Trusts
  • Sector
  • OPK Health Care
  • BFS Real Estate
  • Exchange
  • OPK Nasdaq
  • BFS Nasdaq
  • Market Cap
  • OPK 1.0B
  • BFS 811.7M
  • IPO Year
  • OPK 1995
  • BFS 1993
  • Fundamental
  • Price
  • OPK $1.39
  • BFS $31.91
  • Analyst Decision
  • OPK Buy
  • BFS
  • Analyst Count
  • OPK 4
  • BFS 0
  • Target Price
  • OPK $2.75
  • BFS N/A
  • AVG Volume (30 Days)
  • OPK 2.0M
  • BFS 57.5K
  • Earning Date
  • OPK 11-06-2025
  • BFS 11-06-2025
  • Dividend Yield
  • OPK N/A
  • BFS 7.22%
  • EPS Growth
  • OPK N/A
  • BFS N/A
  • EPS
  • OPK N/A
  • BFS 1.32
  • Revenue
  • OPK $664,029,000.00
  • BFS $277,902,000.00
  • Revenue This Year
  • OPK N/A
  • BFS $10.48
  • Revenue Next Year
  • OPK $0.84
  • BFS $6.52
  • P/E Ratio
  • OPK N/A
  • BFS $24.77
  • Revenue Growth
  • OPK N/A
  • BFS 5.23
  • 52 Week Low
  • OPK $1.11
  • BFS $31.25
  • 52 Week High
  • OPK $2.04
  • BFS $42.39
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.88
  • BFS 37.79
  • Support Level
  • OPK $1.34
  • BFS $31.76
  • Resistance Level
  • OPK $1.44
  • BFS $32.46
  • Average True Range (ATR)
  • OPK 0.04
  • BFS 0.59
  • MACD
  • OPK -0.00
  • BFS -0.16
  • Stochastic Oscillator
  • OPK 50.00
  • BFS 6.07

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

Share on Social Networks: